DeLuca GC, Yates RL, Beale H, Morrow SA. Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights. Brain Pathol. 2015;25:79–98.
Article
PubMed
Google Scholar
Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15:545–58.
Article
CAS
PubMed
Google Scholar
Geloso MC, D’Ambrosi N. Microglial pruning: relevance for synaptic dysfunction in multiple sclerosis and related experimental models. Cells. 2021;10:686.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tanaka M, Vécsei L. Monitoring the redox status in multiple sclerosis. Biomedicines. 2020;8(10):406.
Article
CAS
PubMed Central
Google Scholar
Huang YC, Chien WC, Chung CH, Chang HA, Kao YC, Wan FJ. Risk of psychiatric disorders in multiple sclerosis: a nationwide cohort study in an Asian population. Neuropsychiatr Dis Treat. 2021;17:587–604.
Article
PubMed
PubMed Central
Google Scholar
Tanaka M, Vécsei L. Editorial of Special Issue “Crosstalk between depression, anxiety, and dementia: comorbidity in behavioral neurology and neuropsychiatry.” Biomedicines. 2021;9(5):517.
Article
PubMed
PubMed Central
Google Scholar
DiGiuseppe G, Blair M, Morrow SA. Prevalence of cognitive impairment in newly diagnosed relapsing-remitting multiple sclerosis. Int J MS Care. 2018;20:153–7.
Article
PubMed
PubMed Central
Google Scholar
Jelinek PL, Simpson S, Brown CR, Jelinek GA, Marck CH, De Livera AM, et al. Self-reported cognitive function in a large international cohort of people with multiple sclerosis: associations with lifestyle and other factors. Eur J Neurol. 2019;26:142–54.
Article
CAS
PubMed
Google Scholar
McNicholas N, O’Connell K, Yap SM, Killeen RP, Hutchinson M, McGuigan C. Cognitive dysfunction in early multiple sclerosis: a review. QJM. 2018;111:359–64.
Article
CAS
PubMed
Google Scholar
Moreno-Torres I, Sabín-Muñoz J, García-Merino A. Multiple sclerosis: epidemiology, genetics, symptoms, and unmet needs. Chapter 1. Emerging drugs and targets for multiple sclerosis. 2019; p. 1–32.
Amezcua L, Smith JB, Gonzales EG, Haraszti S, Langer-Gould A. Race, ethnicity, and cognition in persons newly diagnosed with multiple sclerosis. Neurology. 2020;94(14):e1548–56.
Article
PubMed
PubMed Central
Google Scholar
Van Schependom J, D’hooghe MB, Cleynhens K, D’hooge M, Haelewyck MC, De Keyser J, et al. Reduced information processing speed as primum movens for cognitive decline in MS. Mult Scler J. 2015;21(1):83–91.
Article
Google Scholar
Gromisch ES, Fiszdon JM, Kurtz MM. The effects of cognitive-focused interventions on cognition and psychological well-being in persons with multiple sclerosis: a meta-analysis. Neuropsychol Rehabil. 2020;30:767–86.
Article
PubMed
Google Scholar
Macías IMÁ, Ciampi E. Assessment and impact of cognitive impairment in multiple sclerosis: an overview. Biomedicines. 2019;7:22.
Article
Google Scholar
Di Filippo M, Portaccio E, Mancini A, Calabresi P. Multiple sclerosis and cognition: synaptic failure and network dysfunction. Nat Rev Neurosci. 2018;19:599–609.
Article
PubMed
CAS
Google Scholar
Gaetani L, Salvadori N, Chipi E, Gentili L, Borrelli A, Parnetti L, Di Filippo M. Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers. Neural Regen Res. 2021;16:36–42.
Article
PubMed
Google Scholar
Romanelli RJ, Huang Q, Lacy J, Hashemi L, Wong A, Smith A. Multiple sclerosis in a multi-ethnic population from Northern California: a retrospective analysis, 2010–2016. BMC Neurol. 2020;20:163.
Article
PubMed
PubMed Central
Google Scholar
Engel S, Graetz C, Salmen A, Muthuraman M, Toenges G, Ambrosius B, et al. Is APOE ε4 associated with cognitive performance in early MS? Neurol Neuroimmunol Neuroinflamm. 2020;7(4): e728.
Article
PubMed
PubMed Central
Google Scholar
Rocca MA, Amato MP, De Stefano N, Enzinger C, Geurts JJ, Penner IK, et al. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol. 2015;14:302–17.
Article
PubMed
Google Scholar
Kalb R, Beier M, Benedict RH, Charvet L, Costello K, Feinstein A, et al. Recommendations for cognitive screening and management in multiple sclerosis care. Mult Scler J. 2018;24:1665–80.
Article
Google Scholar
Ashrafi F, Behnam B, Ahmadi AM, Taheri SM, Haghighatkhah HR, Pakdaman H, et al. Correlation of MRI findings and cognitive function in multiple sclerosis patients using Montreal Cognitive Assessment test. Med J Islam Repub Iran. 2016;30:357.
PubMed
PubMed Central
Google Scholar
Wong A, Law LSN, Liu W, Wang Z, Lo ES, Lau A, et al. Montreal cognitive assessment one cutoff never fits all. Stroke. 2015;46:3547–50.
Article
PubMed
Google Scholar
Carson N, Leach L, Murphy KJ. A re-examination of Montreal cognitive assessment (MoCA) cutoff scores. Int J Geriatr Psychiatry. 2018;33:379–88.
Article
PubMed
Google Scholar
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73.
Article
PubMed
Google Scholar
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–5218.
Article
CAS
PubMed
Google Scholar
Hatipoglu H, Kabay SC, Hatipoglu MG, Ozden H. Expanded disability status scale-based disability and dental-periodontal conditions in patients with multiple sclerosis. Med Princ Pract. 2016;25:49–55.
Article
PubMed
Google Scholar
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.
Article
PubMed
Google Scholar
Chang YT, Chang CC, Lin HS, Huang CW, Chang WN, Lui CC, et al. Montreal cognitive assessment in assessing clinical severity and white matter hyperintensity in Alzheimer’s disease with normal control comparison. Acta Neurol. 2012;21:64–73.
Google Scholar
Guo QH, Cao XY, Zhou Y, Zhao QH, Ding D, Hong Z. Application study of quick cognitive screening test in identifying mild cognitive impairment. Neurosci Bull. 2010;26(1):47–54.
Article
PubMed
PubMed Central
Google Scholar
Ömerhoca S, Akkaş SY, İçen NK. Multiple sclerosis: diagnosis and differential diagnosis. Arch Neuropsychiatry. 2018;55(Suppl. 1):S1–9.
Google Scholar
Hoang H, Laursen B, Stenager EN, Stenager E. Psychiatric co-morbidity in multiple sclerosis: the risk of depression and anxiety before and after MS diagnosis. Mult Scler J. 2016;22:347–53.
Article
CAS
Google Scholar
Thormann A, Sørensen PS, Koch-Henriksen N, Laursen B, Magyari M. Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality. Neurology. 2017;89:1668–75.
Article
PubMed
Google Scholar
Benedict RH, Zivadinov R. Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol. 2011;7:332–42.
Article
PubMed
Google Scholar
Vanotti S, Smerbeck A, Eizaguirre MB, Saladino ML, Benedict RRH, Caceres FJ. BICAMS in the Argentine population: relationship with clinical and sociodemographic variables. Appl Neuropsychol Adult. 2018;25:424–33.
Article
PubMed
Google Scholar
Pouramiri M, Azimian M, Akbarfahimi N, Pishyareh E, Hossienzadeh S. Investigating the relationship between individual and clinical characteristics and executive dysfunction of multiple sclerosis individuals. Arch Rehabil. 2019;20:114–23.
Article
Google Scholar
Hassanshahi E, Asadollahi Z, Azin H, Hassanshahi J, Hassanshahi A, Azin M. Cognitive function in multiple sclerosis patients based on age, gender, and education level. Acta Med Iran. 2020;58(10):500–7.
Google Scholar
Shaygannejad V, Afshar H. The frequency of cognitive dysfunction among multiple sclerosis patients with mild physical disability. J Isfahan Med Sch. 2012;29:167.
Google Scholar
Tam JW, Schmitter-Edgecombe M. The role of processing speed in the brief visuospatial memory test–revised. Clin Neuropsychol. 2013;27:962–72.
Article
PubMed
PubMed Central
Google Scholar
Amato MP, Ponziani G, Pracucci G, Bracco L, Siracusa G, Amaducci L. Cognitive impairment in early-onset multiple sclerosis Pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol. 1995;52:168–72.
Article
CAS
PubMed
Google Scholar
Amato MP, Ponziani G, Siracusa G, Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol. 2001;58:1602–6.
Article
CAS
PubMed
Google Scholar
Lynch SG, Parmenter BA, Denney DR. The association between cognitive impairment and physical disability in multiple sclerosis. Mult Scler. 2005;11:469–76.
Article
PubMed
Google Scholar
Rogers JM, Panegyres PK. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations. J Clin Neurosci. 2007;14:919–27.
Article
PubMed
Google Scholar
Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008;7:1139–51.
Article
PubMed
Google Scholar
Achiron A, Chapman J, Magalashvili D, Dolev M, Lavie M, Bercovich E, et al. Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study. PLoS ONE. 2013;8: e71058.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dackovic J, Pekmezovic T, Mesaros S, Dujmovic I, Stojsavljevic N, Martinovic V, et al. The Rao’s Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population. Neurol Sci. 2016;37:1475–81.
Article
PubMed
Google Scholar
Ruano L, Portaccio E, Goretti B, Niccolai C, Severo M, Patti F, et al. Age, and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Mult Scler. 2017;23:1258–67.
Article
PubMed
Google Scholar
Ouellette R, Bergendal Å, Shams S, Martola J, Mainero C, Kristoffersen M, et al. Lesion accumulation is predictive of long-term cognitive decline in multiple sclerosis. Mult Scler Relat Disord. 2018;21:110–6.
Article
PubMed
Google Scholar
Daams M, Steenwijk MD, Schoonheim MM, Wattjes MP, Balk LJ, Tewarie PK, et al. Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis. Mult Scler. 2016;22:608–19.
Article
PubMed
Google Scholar
Aksoy S, Timer E, Mumcu S, Akgün M, Kırak E, Örken DN, et al. Screening for cognitive impairment in multiple sclerosis with MOCA test. Turk J Neurol. 2013;19:52–5.
Google Scholar
Rimkus CM, Avolio IMB, Miotto EC, Pereira SA, Mendes MF, Callegaro D, et al. The protective effects of high-education levels on cognition in different stages of multiple sclerosis. Mult Scler Relat Disord. 2018;22:41–8.
Article
PubMed
Google Scholar
Eijlers AJC, Meijer KA, van Geest Q, Geurts JJG, Schoonheim MM. Determinants of cognitive impairment in patients with multiple sclerosis with and without atrophy. Neuroradiology. 2018;288:544–51.
Google Scholar
Caparelli-Dáquer EM, Oliveira-Souza R, Moreira Filho PF. Judgment of line orientation depends on gender, education, and type of error. Brain Cogn. 2009;69:116–20.
Article
PubMed
Google Scholar
Maloni H. Cognitive impairment in multiple sclerosis. J Nurse Pract. 2018;14:172–7.
Article
Google Scholar
Patti F, Nicoletti A, Messina S, Bruno E, Fermo SL, Quattrocchi G, et al. Prevalence and incidence of cognitive impairment in multiple sclerosis: a population-based survey in Catania, Sicily. J Neurol. 2015;262(4):923–30.
Article
PubMed
Google Scholar
Amato MP, Prestipino E, Bellinvia A, Niccolai C, Razzolini L, Pastò L, et al. Cognitive impairment in multiple sclerosis: an exploratory analysis of environmental and lifestyle risk factors. PLoS ONE. 2019;14(10): e0222929.
Article
CAS
PubMed
PubMed Central
Google Scholar
Carotenuto A, Moccia M, Costabile T, Signoriello E, Paolicelli D, Simone M, et al. Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis. Sci Rep. 2019;9:18074.
Article
CAS
PubMed
PubMed Central
Google Scholar
Migliore S, Ghazaryan A, Simonelli I, Pasqualetti P, Squitieri F, Curcio G, et al. Cognitive impairment in relapsing-remitting multiple sclerosis patients with very mild clinical disability. Behav Neurol. 2017. https://doi.org/10.1155/2017/7404289.
Article
PubMed
PubMed Central
Google Scholar
Dagenais E, Rouleau I, Demers M, Jobin C, Roger E, Chamelian L, et al. Value of the MoCA test as a screening instrument in multiple sclerosis. Can J Neurol Sci. 2013;40(3):410–5.
Article
PubMed
Google Scholar
Oset M, Stasiolek M, Matysiak M. Cognitive dysfunction in the early stages of multiple sclerosis—how much and how important? Curr Neurol Neurosci Rep. 2020. https://doi.org/10.1007/s11910-020-01045-3.
Article
PubMed
PubMed Central
Google Scholar